![]() |
Medical oncologist from San Martín de Porres University, with specialized studies at the National Institute of Neoplastic Diseases (INEN). Master's degree in Medical Oncology from San Martín de Porres University. He has complemented his training with a diploma in Public Health from the Swiss School of Public Health and a diploma in Molecular Biology applied to Clinical Oncology from the University of Liège. He works as a medical oncologist at the National Institute of Neoplastic Diseases, Clínica Aliada, and Clínica Angloamericana. He has held positions such as Executive Director of the Research Department at INEN and President of the Pharmacotherapeutic Committee at INEN. His experience includes research in clinical oncology, bone marrow transplantation, and the development of therapeutic protocols in cancer. He is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Peruvian Society of Medical Oncology (SPOM), and the Peruvian Society of Cancerology. |
![]() |
Medical oncologist from Ricardo Palma University. He has over 15 years of experience in cancer research. Currently, he works at the National Institute of Neoplastic Diseases, focusing on breast, urogenital, and melanoma cancers. In academia, he teaches at San Juan Bautista Private University. He has collaborated with national and international researchers and is a member of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). |
![]() |
Medical oncologist from the University of San Martín de Porres, with specialized studies at the National Institute of Neoplastic Diseases. Master's degree in Molecular Oncology from the National Cancer Research Center (CNIO) and Master's degree in Health Management from Centrum PUCP. Doctor of Medicine from the University of San Martín de Porres. She works as a medical oncologist at the National Institute of Neoplastic Diseases and at Oncosalud-AUNA. She has held leadership positions in the Peruvian Society of Medical Oncology and the Peruvian Society of Mastology, in addition to having been Director of Medicine at INEN. She is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Medical Oncology (SPOM). |
![]() |
Medical oncologist from the Universidad Mayor de San Simón, with specialized studies at the National Institute of Neoplastic Diseases. Master of Medicine from the Universidad San Martín de Porres. He has complemented his training with a diploma in Medical Auditing and a diploma in Molecular Biology applied to Clinical Oncology from the European School of Oncology. He serves as Executive Director of the Department of Oncological Medicine at the National Institute of Neoplastic Diseases and as a medical oncologist at the Oncosalud Clinic. He has participated in international congresses and training programs on breast cancer and sarcomas in Europe and Latin America. He is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Peruvian Society of Medical Oncology (SPOM), and the Peruvian Society of Cancerology. |
![]() |
Medical oncologist from Universidad Científica del Sur, with specialized training at the National Institute of Neoplastic Diseases. Master of Medicine with a specialization in Medical Oncology from Universidad Peruana Cayetano Heredia. He has complemented his training with a diploma in Molecular Biology applied to Clinical Oncology from the University of Liège and training in breast cancer and melanoma in Europe. He works as a medical oncologist at the National Institute of Neoplastic Diseases and at Oncosalud-AUNA. His practice focuses on the management of breast cancer, melanoma, and genitourinary tumors. He has worked in clinical research and in the pharmaceutical industry as a medical manager in oncology. He is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Mastology (SPM). |
![]() |
Medical oncologist from the National University of San Marcos, with specialized studies at the National Institute of Neoplastic Diseases. Master's degree in Molecular Oncology from King Juan Carlos University. He has complemented his training with courses at the MD Anderson Cancer Center and the European Institute of Oncology, in addition to a diploma in Molecular Biology applied to Clinical Oncology. He works as a medical oncologist at the National Institute of Neoplastic Diseases and at Clínica San Juan de Dios, with experience in clinical trials and medical oncology research. He has participated in numerous international conferences and has contributed to studies on lung cancer and solid tumors. Member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the American Association for Cancer Research (AACR). |
![]() |
Medical oncologist from the University of San Martín de Porres, with specialized studies at the National Institute of Neoplastic Diseases. Master of Medicine from Cayetano Heredia University. She has complemented her training with clinical oncology courses in Spain and Belgium, as well as a diploma in Molecular Biology applied to Clinical Oncology. She works as a medical oncologist at the National Institute of Neoplastic Diseases and at Oncosalud-AUNA. She has experience in the management of breast and genitourinary cancers, as well as in clinical oncology research. She has served as chief resident at INEN and as a reviewer for international scientific journals. She is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Medical Oncology (SPOM). |
|
Medical oncologist from the University of San Martín de Porres, with specialized studies at the National Institute of Neoplastic Diseases. Master of Medicine from Cayetano Heredia University. He has complemented his training with fellowships at the MD Anderson Cancer Center and the National Cancer Institute of Brazil, in addition to a diploma in Molecular Biology applied to Clinical Oncology. He works as a medical oncologist at the National Institute of Neoplastic Diseases and at Oncosalud-AUNA. His clinical experience focuses on hematological malignancies and lymphomas, with active participation in international clinical trials and the development of oncology management guidelines. He is a member of the European Hematology Association, the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Medical Oncology (SPOM). |
![]() |
Medical oncologist from the University of San Martín de Porres, with specialized studies at the National Institute of Neoplastic Diseases. Master of Medicine from Cayetano Heredia University and Master of Medical Oncology from the University of Girona. She also holds an international diploma in Molecular Biology applied to Clinical Oncology from the University of Liège and completed a research fellowship at Massachusetts General Hospital. She works as a medical oncologist at the National Institute of Neoplastic Diseases and at Oncosalud-AUNA. She has led clinical oncology research and served as head of the Outpatient Chemotherapy Unit at INEN. She has numerous publications in international scientific journals. She is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Medical Oncology (SPOM). |
![]() |
Medical oncologist from the Universidad Científica del Sur, with specialized training at the National Institute of Neoplastic Diseases. She has furthered her training in gastrointestinal and genitourinary tumors and immunotherapy at the Mataró-ICO Hospital in Barcelona, Spain. She works as a medical oncologist at the National Institute of Neoplastic Diseases and as a Chemotherapy Supervisor at the Clínica Internacional. She is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the Peruvian Society of Medical Oncology (SPOM). |









